AzTrials
AzTrials

Palliative CarePALL-ICUNCT03287323

Proactive Palliative Care Intervention in a Surgical ICU: Influence on Family Satisfaction and Patient Distress

A study testing Proactive Palliative Care in people with Palliative Care, run by Johannes Gutenberg University Mainz at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients will be identified according to pre-defined trigger criteria for a palliative intervention. One hundred patients of a control group will receive standard intensive care treatment (Usual Care Group). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Palliative Care
What is being tested?
Proactive Palliative Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteGermany
Study dates
19 Jun 2017to Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • need for intensive care for more than 3 days and at least one of the following trigger criteria:
  • known advanced cancer
  • severe cognitive impairment or dementia
  • multi-organ failure

Who cannot join

  • Patients who already receive palliative care

Trial locations and contacts

1 site in 1 country.

Germany1 site, 1 recruiting
  • Department of Anaesthesiology, University Medical Center of Johannes Gutenberg-University Mainz, Germany

    Mainz, 55131

    Rita Laufenberg-Feldmann, M.D., +49 (0) 6131 17 ext. 6751, Rita.Laufenberg@unimedizin-mainz.de

    Marion Ferner, M.D., +49 (0) 6131 17 ext. 6751, Marion.Ferner@unimedizin-mainz.de

    Recruiting

Other trials in Germany

About this study

Official title: The Influence of a Proactive Palliative Care Intervention on Family Satisfaction and Biopsychosocial Problem-related Distress of Patients in a Surgical Intensive Care Unit: A Prospective Single-center Interventional Study

Patients will be identified according to pre-defined trigger criteria for a palliative intervention. One hundred patients of a control group will receive standard intensive care treatment (Usual Care Group). Patients' biopsychosocial problem-related distress will be evaluated and family satisfaction with intensive care will be measured with standardized questionnaires. In the subsequent intervention part of the study one hundred patients will additionally be offered a palliative care treatment (Proactive Care Group) and patients' biopsychosocial problem-related distress as well as family satisfaction will also be evaluated.

Read the detailed description

The project consists of different consecutive parts:

  1. Trigger criteria: Trigger criteria for patients with unmet palliative care needs in an intensive care unit have been specified prior to start of the clinical study by survey of staff of the surgical intensive care unit (intensivists and nursing staff): Trigger criteria include a) advanced cancer, b) multi-organ failure, c) severe cognitive impairment or dementia
  2. Clinical study: Proactive palliative care intervention vs. standard care for intensive care patients. Initially patients fulfilling the defined trigger criteria will be enrolled in the standard care group (Group 1). In the intervention part of the study, enrolled patients will be offered a set of different palliative care interventions in addition to standard intensive care (Group 2). In both groups, family satisfaction will be evaluated with the FS-ICU-24 (Family Satisfaction Intensive Care) questionnaire after discharge of the patients from the ICU. 8 weeks (60 days +/- 7 days) after inclusion in the study, patients' biopsychosocial distress will be assessed with standardized patient questionnaires (NCCN Distress thermometer, PHQ-2 Patient Health Questionnaire). One year after inclusion in the study, patients' functional status will be evaluated in a telephone interview using the Barthel Index. Planned duration of clinical part of the study: 3 years, thereof
  3. Patient-related: Duration of palliative care intervention: approx. 60 mins for each patient contact. The number of interventions depends on the duration of ICU stay per patient. Follow-up per patient until 1 year after enrolment.
  4. Study-related: The clinical study starts with the enrollment of the first ICU patient. Data will be collected between the admission of the patient in the ICU until discharge from ICU and hospital discharge, respectively. Follow-up visits will be performed 8 weeks and 1 year after enrolment. Patients will be recruited over an estimated period of approx. 3 years, assuming that 1-2 patients per week can be included. Follow-up data will be collected up to 1 year after last patient in.
  5. Termination of study including data analysis and evaluation, and publication of the study results: approx. 1 year
Conditions
Palliative Care
Being tested
Proactive Palliative Care
Keywords
palliative care, surgical intensive care, family satisfaction, ICU decision-making, end-of-life care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Proactive Palliative CareOther

    In the intervention part of the study, enrolled patients will be offered a set of different palliative care interventions, including symptom management, advance care planning, palliative physiotherapy, social and spiritual support, communication with patients and caregivers, in addition to standard intensive care.

Study groups in NCT03287323
Study groupRoleWhat they receive
Usual Care GroupNo interventionOne hundred patients of a control group will receive standard intensive care treatment (Usual Care Group).
Proactive Palliative CareOtherOne hundred patients will additionally be offered a palliative care Intervention (Proactive Palliative Care Group).
Receives: Other: Proactive Palliative Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. family satisfaction in a surgical intensive care unit using a standardized questionnaire (FS-ICU).

    To evaluate the effects of a proactive palliative care intervention for selected patients with unmet palliative needs on family satisfaction in a surgical intensive care unit using a standardized questionnaire (FS-ICU).

    Measured: after discharge from ICU, up to 1 year after enrolment

Secondary outcomes (6)
  1. Patients' biopsychosocial problem-related distress after intensive care treatment measured with the NCCN distress thermometer

    To evaluate the effects of a proactive palliative care intervention for selected patients with unmet palliative needs in a surgical intensive care unit on patients' self-reported distress, measured with the NCCN distress thermometer

    Measured: 60 days +/- 7 days after enrolment

  2. Intensive care length of stay

    To evaluate the effects of a proactive palliative care intervention for selected patients with unmet palliative needs in a surgical intensive care unit on ICU length of stay, measured as days in ICU.

    Measured: up to 1 year after enrolment

  3. Duration of hospitalization

    To evaluate the effects of a proactive palliative care intervention for selected patients with unmet palliative needs in a surgical intensive care unit on hospital length of stay, measured as days in hospital.

    Measured: up to 1 year after enrolment

  4. 1-year Patient survival

    To evaluate the effects of a proactive palliative care intervention for selected patients with unmet palliative needs in a surgical intensive care unit on overall survival of patients.

    Measured: up to 1 year after enrolment

  5. Organ replacement therapy

    To evaluate organ dysfunction and duration of replacement therapy, measured as days of mechanical ventilation and/or days of ECMO and/or days of hemofiltration, if applicable

    Measured: up to 1 year after enrolment

  6. Functional assessment after 1 year

    To evaluate functionality with regard to activities of daily living (Barthel Index)

    Measured: up to 1 year after enrolment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2017
  2. Study start19 Jun 2017
  3. Primary completionApr 2020 (estimated)
  4. Study completionJul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Sequential
Model description
Prospective before-and after interventional study including 100 patients who receive usual intensive care followed by an interventional part with 100 patients who receive additional palliative care consultations
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03287323
Sponsor's protocol ID
837.108.17 (10942)
Acronym
PALL-ICU
Status last verified
Sep 2017
First submitted
8 Sep 2017
Last updated
19 Sep 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hua M, Wunsch H. Integrating palliative care in the ICU. Curr Opin Crit Care. 2014 Dec;20(6):673-80. doi: 10.1097/MCC.0000000000000149.

    PubMed 25233330
  • Heyland DK, Tranmer JE; Kingston General Hospital ICU Research Working Group. Measuring family satisfaction with care in the intensive care unit: the development of a questionnaire and preliminary results. J Crit Care. 2001 Dec;16(4):142-9. doi: 10.1053/jcrc.2001.30163.

    PubMed 11815899
  • Wall RJ, Engelberg RA, Downey L, Heyland DK, Curtis JR. Refinement, scoring, and validation of the Family Satisfaction in the Intensive Care Unit (FS-ICU) survey. Crit Care Med. 2007 Jan;35(1):271-9. doi: 10.1097/01.CCM.0000251122.15053.50.

    PubMed 17133189
  • Selecky PA, Eliasson CA, Hall RI, Schneider RF, Varkey B, McCaffree DR; American College of Chest Physicians. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. 2005 Nov;128(5):3599-610. doi: 10.1378/chest.128.5.3599.

    PubMed 16304319
  • Mosenthal AC, Weissman DE, Curtis JR, Hays RM, Lustbader DR, Mulkerin C, Puntillo KA, Ray DE, Bassett R, Boss RD, Brasel KJ, Campbell M, Nelson JE. Integrating palliative care in the surgical and trauma intensive care unit: a report from the Improving Palliative Care in the Intensive Care Unit (IPAL-ICU) Project Advisory Board and the Center to Advance Palliative Care. Crit Care Med. 2012 Apr;40(4):1199-206. doi: 10.1097/CCM.0b013e31823bc8e7.

    PubMed 22080644
  • Braus N, Campbell TC, Kwekkeboom KL, Ferguson S, Harvey C, Krupp AE, Lohmeier T, Repplinger MD, Westergaard RP, Jacobs EA, Roberts KF, Ehlenbach WJ. Prospective study of a proactive palliative care rounding intervention in a medical ICU. Intensive Care Med. 2016 Jan;42(1):54-62. doi: 10.1007/s00134-015-4098-1. Epub 2015 Nov 10.

    PubMed 26556622

Questions about this trial

What is this clinical trial studying?

A study testing Proactive Palliative Care in people with Palliative Care, run by Johannes Gutenberg University Mainz at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rita Laufenberg-Feldmann, M.D. (+49 (0) 6131 17 ext. 6751, rita.Laufenberg@unimedizin-mainz.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

family satisfaction in a surgical intensive care unit using a standardized questionnaire (FS-ICU). (time frame: after discharge from ICU, up to 1 year after enrolment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03287323, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
PALL-ICU Clinical Trial NCT03287323 | AzTrials